567 related articles for article (PubMed ID: 32539623)
1. A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2.
Hanley BP; Keen S; Church G
Rejuvenation Res; 2020 Aug; 23(4):281-283. PubMed ID: 32539623
[No Abstract] [Full Text] [Related]
2. The Race to Develop a COVID-19 Vaccine.
Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132
[TBL] [Abstract][Full Text] [Related]
3. Keeping track of the SARS-CoV-2 vaccine pipeline.
Parker EPK; Shrotri M; Kampmann B
Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
[TBL] [Abstract][Full Text] [Related]
4. Coronavirus vaccines get a biotech boost.
Dance A
Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847
[No Abstract] [Full Text] [Related]
5. How the pandemic might play out in 2021 and beyond.
Scudellari M
Nature; 2020 Aug; 584(7819):22-25. PubMed ID: 32760050
[No Abstract] [Full Text] [Related]
6. Understanding COVID-19 vaccine efficacy.
Lipsitch M; Dean NE
Science; 2020 Nov; 370(6518):763-765. PubMed ID: 33087460
[No Abstract] [Full Text] [Related]
7. Emergence of a novel human coronavirus threatening human health.
Poon LLM; Peiris M
Nat Med; 2020 Mar; 26(3):317-319. PubMed ID: 32108160
[TBL] [Abstract][Full Text] [Related]
8. Dozens to be deliberately infected with coronavirus in UK 'human challenge' trials.
Callaway E
Nature; 2020 Oct; 586(7831):651-652. PubMed ID: 33082550
[No Abstract] [Full Text] [Related]
9. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
Heininger U
Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
[No Abstract] [Full Text] [Related]
10. Developing Covid-19 Vaccines at Pandemic Speed.
Lurie N; Saville M; Hatchett R; Halton J
N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
[No Abstract] [Full Text] [Related]
11. Progress and Concept for COVID-19 Vaccine Development.
Wu SC
Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
[No Abstract] [Full Text] [Related]
12. China's coronavirus vaccines are leaping ahead - but face challenges as virus wanes.
Cyranoski D
Nature; 2020 Aug; 584(7819):17-18. PubMed ID: 32737453
[No Abstract] [Full Text] [Related]
13. Riding the coronacoaster of uncertainty.
The Lancet Infectious Diseases
Lancet Infect Dis; 2020 Jun; 20(6):629. PubMed ID: 32422202
[No Abstract] [Full Text] [Related]
14. Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.
Moise L; Ross TM; Hoft DF; Martin WD; De Groot AS
Expert Rev Vaccines; 2020 Sep; 19(9):781-784. PubMed ID: 32962468
[No Abstract] [Full Text] [Related]
15. [Not Available].
Nau JY
Rev Med Suisse; 2020 Jun; 16(696):1176-1177. PubMed ID: 32496711
[No Abstract] [Full Text] [Related]
16. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E
J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510
[TBL] [Abstract][Full Text] [Related]
17. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
18. All eyes on a hurdle race for a SARS-CoV-2 vaccine.
Gaebler C; Nussenzweig MC
Nature; 2020 Oct; 586(7830):501-502. PubMed ID: 33077943
[No Abstract] [Full Text] [Related]
19. COVID-19 and Bacillus Calmette-Guérin: What is the Link?
Hegarty PK; Sfakianos JP; Giannarini G; DiNardo AR; Kamat AM
Eur Urol Oncol; 2020 Jun; 3(3):259-261. PubMed ID: 32327396
[TBL] [Abstract][Full Text] [Related]
20. Protect against market exclusivity in the fight against COVID-19.
't Hoen E
Nat Med; 2020 Jun; 26(6):813. PubMed ID: 32382151
[No Abstract] [Full Text] [Related]
[Next] [New Search]